-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.ISIN US00287YCY32-
AbbvieBörse Börse MünchenISIN US00287YDA47Symbol 4AB
-
AbbvieBörse Börse FrankfurtISIN US00287YBP34Symbol 4AB
-
AbbvieBörse Börse MünchenISIN US00287YCT47
-
AbbvieBörse Tradegate System der Deutsche Börse AG (60%)ISIN US00287YCZ07Symbol 4AB
-
ABBVIE INCBörse Börse BerlinISIN US00287YBK47Symbol 4AB
-
ABBVIE INCBörse Börse DüsseldorfISIN US00287YCR80Symbol 4AB
-
ABBVIE INCBörse Quotrix System der Börse DüsseldorfISIN US00287YDB20Symbol 4AB
-
ABBVIE INCBörse Gettex System der Börse MünchenISIN XS2125913603Symbol 4AB
-
ABBVIE INCBörse Börse StuttgartISIN US00287YCU10Symbol 4AB
-
ISIN US00287YAU38Symbol ABBV
-
ISIN US00287YBY41
-
ISIN US00287YCS63Symbol 4AB
-
ISIN US00287YCY32
-
ISIN US00287YCV92
-
AbbVie Inc.Börse Bolsa Mexicana de Valore Mexiko-StadtISIN US00287YBM03
-
AbbVie Inc.Börse Bolsa de Comercio de Buenos AiresISIN US00287YBC21
-
Abbvie outperformed den DAX um +34 % vom 01.10.2014 bis 05.08.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 95,14 USD +8,16%
Portrait der Abbvie Aktie
Das Unternehmen Abbvie aus USA beschäftigt 50.000 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Die Abbvie Aktie konnte seit dem 01.10.2014 eine Rendite von 101% erwirtschaften.
Abbvie ist in mehr als 87 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Morningstar Dividend Leaders ETF (CAD-Hedged) gewichtet Abbvie mit 7,03% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Abbvie Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Abbvie am höchsten gewichtet ist Insgesamt in 87 ETFs enthalten
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
368 News & Informationen zur Abbvie Aktie
Continue To Ride Johnson & Johnson Stock For Higher Levels
We believe that the stock price of Johnson & Johnson has more room for growth from its current levels of $166. JNJ stock is up only 10% from the levels of around $150 it was at in mid-February, 2020, before the pandemic led to a steep correction in the stock markets. This marks an underperformance..
3 Dividend Stocks That Are Dirt Cheap Right Now
Most stocks are priced at a premium. But these are bargains that also offer solid dividends.
On the congressional-comeback trail, Democrat Harley Rouda appears to violate the federal STOCK Act
Rep. Harley Rouda, a Democrat from California, appears to have violated a provision of the federal STOCK Act that's designed to make lawmake…
On the congressional-comeback trail, Democrat Harley Rouda appears to violate the federal STOCK Act
Congress members love buying and selling stocks. Insider's weekly congressional financial report details how lawmakers are investing and making money.
Global $25+ Million Chloromethyl Isopropyl Carbonate (Value, Volume) Market to 2026
DUBLIN, July 5, 2021 /PRNewswire/ — The 'Global Chloromethyl Isopropyl Carbonate (CMIC) Market (Value, Volume) – Analysis By Application, Type, B…
Global $25 Million Chloromethyl Isopropyl Carbonate (Value, Volume) Market To 2026
DUBLIN, July 5, 2021 /PRNewswire/ — The “Global Chloromethyl Isopropyl Carbonate (CMIC) Market (Value, Volume) – Analysis By Application, Type, By Region, By
Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
3 Warren Buffett Stocks to Buy in July
You might call these the legendary investor's
AbbVie Stock: The Path To 30% Annual Returns (NYSE:ABBV)
AbbVie has been over-punished for its looming loss of Humira. ABBV stock is way too cheap, and over time could see a rerating that bring 30% annual returns to investors. Read more here.
These COVID Therapies Appear to Be the Best and Worst at Treating New Variants
Here's how several leading COVID-19 antibody therapies compare based on pre-clinical testing.
How to Invest in Cannabis (Without Buying Cannabis Stocks)
Ancillary companies provide cannabis businesses with materials, technology and services without ever “touching” the plant.
Insights On The Eye Care Global Market To 2026 – Featuring EssilorLuxottica, Bausch Health And Alcon Among Others
DUBLIN, July 2, 2021 /PRNewswire/ — The “Global Eye Care Market, By Product Type (Eyeglasses, Eye Drops, Contact Lens, Intraocular Lens, Eye Vitamins,
Got $400? 3 Fantastic Dividend Stocks to Buy Right Now
You'll get more than just dividends with these three stocks.
Worldwide Eye Care Industry to 2026 – Growing Prevalence of Different Ocular Problems is Driving Growth – ResearchAndMarkets.com
The
Aesthetic Laser and Energy Devices Market in Health Care Equipment in the US | Technavio
/PRNewswire/ — The healthcare equipment industry is expected to have a positive impact due to the spread of the COVID-19 pandemic. The market demand is…
Intrauterine Contraceptive Devices Market in Health Care Equipment Industry | Technavio
NEW YORK, June 30, 2021 /PRNewswire/ –The healthcare industry is expected to have a positive impact due to the spread of the COVID-19 pandemic. T…
Intrauterine Contraceptive Devices Market in Health Care Equipment Industry | Technavio
/PRNewswire/ — The healthcare industry is expected to have a positive impact due to the spread of the COVID-19 pandemic. The market demand is expected to…
Top Biotech Companies by Market Cap
What are the biggest names in biotechnology? We count down the five top biotech companies based on market cap and share what they're up to.
AbbVie: Is the Price Right for Long-Term Investment?
The pharma giant's stock is up 18% in the past year. Have investors missed the boat or is the stock still a buy?
AbbVie Is Firing On All Cylinders (NYSE:ABBV)
AbbVie is well on track to replace expected declines in future HUMIRA sales. Read more to know why ABBV looks primed to deliver a very strong decade.
Global Pharmaceutical Contract Manufacturing Market To Reach $130.2 Billion By 2026
SAN FRANCISCO, June 29, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Global Pharmaceutical Contract Manufacturing Market to Reach $130.2 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
New York takes Teva, McKesson, others to trial over opioids By Reuters
New York takes Teva, McKesson, others to trial over opioids
3 Huge Monthly Dividends Set To Soar (One Yields An Incredible 7.6%)
Stocks Analysis by Contrarian Outlook (Brett Owens) covering: S&P 500, SPDR® S&P 500, iShares Biotechnology ETF, Amazon.com Inc. Read Contrarian Outlook (Brett Owens)'s latest article on Investing.com
Age-related Macular Degeneration Market In Pharmaceutical Industry | Technavio
NEW YORK, June 28, 2021 /PRNewswire/ — The age-related macular degeneration market will witness USD 4.00 billion growth during 2021-2025, according to the
SHAREHOLDER ALERT: WeissLaw LLP Reminds SPRT, MNR, UFS, and SOLY Shareholders About Its Ongoing Investigations
/PRNewswire/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this…
Who Are the Dividend Aristocrats in 2021?
Dividend Aristocrats have grown dividends consecutively for at least 25 years. This infographic ranks all 65 companies by years and yield
Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. To Board Of Directors
Dr. Brun's early and late-stage clinical development expertise in autoimmune, neurologic, and renal disease areas aligns well with Cabaletta's rapidly emerging
These 3 High-Dividend Stocks Have Cathie Wood's Seal of Approval
Some might be surprised to see income-paying stocks among the ARK Invest founder's high-growth picks.
J&J to pay US$263m to settle opioid suits
JOHNSON & Johnson said on Saturday it will pay US$263 million to resolve claims it fueled an opioid epidemic in New York state and two of its largest counties.
The settlements remove the drugmaker from
J&J to pay $263 million in New York opioid settlements, avoids trial
NEW YORK -Johnson & Johnson said on Saturday it will pay $263 million to resolve claims it fueled an opioid epidemic in New York state and two of its largest counties….
Nike And Wells Fargo Lead The SPY Higher Friday
U.S. indices continued higher Friday after President Joe Biden declared that the White House had struck an infrastructure deal with a bipartisan gr…
AbbVie (ABBV) Provides Update Regarding RINVOQ®
How Will the Drop in Biogen’s Share Price Hit Buffett’s Portfolio? – 24
One of six drugmakers in Berkshire Hathaway's portfolio, dropped by more than 6% on Thursday, but it remains the best performer of the six investments.
AbbVie : CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic Dermatitis
NORTH CHICAGO, Ill., June 25, 2021 /PRNewswire/ — AbbVie today announced the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending… | June 25, 2021
CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic Dermatitis
/PRNewswire/ — AbbVie (NYSE: ABBV) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a…
JPMorgan Chase Top 50 Holdings : InvestmentClub
62.8k members in the InvestmentClub community. Where a virtual crowdsourced investment club manages a virtual $10M portfolio based on value and …
Redmile Group, LLC Buys Jazz Pharmaceuticals PLC, Seagen Inc, Medtronic PLC, Sells AbbVie Inc, Gilead Sciences Inc, 1Life Healthcare Inc
GuruFocus Article or News written by insider and the topic is about:
AbbVie Inc. (ABBV) Exercises Right to Acquire TeneoOne
2 Marijuana Stocks To Watch Before The End Of The Month